Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Luiz Paulo De Oliveira Gireli"'
Autor:
Lauro Damasceno de Carvalho Faria, Glayson da Silveira Martins, Luiz Paulo de Oliveira Gireli, Daniel Alves Branco Ribeiro, Samuel Nuno Pereira Lima
Publikováno v:
Research, Society and Development; Vol. 10 No. 9; e22710918093
Research, Society and Development; Vol. 10 Núm. 9; e22710918093
Research, Society and Development; v. 10 n. 9; e22710918093
Research, Society and Development
Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
Research, Society and Development; Vol. 10 Núm. 9; e22710918093
Research, Society and Development; v. 10 n. 9; e22710918093
Research, Society and Development
Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
Introduction: Dieulafoy’s lesion (DL) is occasioned by a tortuous, persistent and large caliber artery that emerges the mucosa from the submucosa of an organ, eventually triggering gastrointestinal bleeding in the presence of eroding factors of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d640b2c2e6098329b41ef004a6821cf3
https://rsdjournal.org/index.php/rsd/article/view/18093
https://rsdjournal.org/index.php/rsd/article/view/18093
Autor:
Mauricio Kauark Amoedo, Rogério Camargo Pinheiro Alves, Felipe José Fernandez Coimbra, Almir Galvão Vieira Bitencourt, João Paulo Kawaoka Matushita Junior, Rubens Chojniak, Charles Edouard Zurstrassen, Marcos Duarte Guimarães, Aline Cristine Barbosa Santos Cavalcante, Luiz Paulo De Oliveira Gireli, Chiang Jeng Tyng, Paula Nicole Vieira Pinto Barbosa
Publikováno v:
Minimally invasive therapyallied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy. 26(4)
Aim: To evaluate the effects of HepaSphere 50–100 μm (Merit Medical) as a doxorubicin carrier and embolization agent for the treatment of hepatocellular carcinoma (HCC).Material and methods: A prospective analysis of 18 patients recruited from a n